Streetbeat News

Products Services

CYBN

Cybin Inc. is set to initiate a pivotal Phase 3 study for CYB003 in Major Depressive Disorder imminently, with 12-month efficacy data from its Phase 2 study expected in early Q4 2024. Additionally, Phase 2 results for CYB004 in Generalized Anxiety Disorder are anticipated by the end of 2024 or early 2025. The company has strengthened its R&D team with new leadership.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 9:40 pm

QQQ

SPY

VIX

Traders are preparing for potential market volatility on Friday due to the 'Triple Witching' event, where over $5 trillion in options are set to expire. This could disrupt the recent market rally spurred by the Federal Reserve's rate cut. Goldman Sachs highlights the record-breaking options expiration and recommends hedging with VIX calls.

Portfolio Pulse from Piero Cingari

September 19, 2024 | 8:54 pm

ANGO

AngioDynamics has initiated the RECOVER-AV clinical trial to evaluate the AlphaVac F18⁸⁵ system for treating pulmonary embolism and assessing long-term functional outcomes.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 8:41 pm

AMZN

CMCSA

DIS

DKNG

The NFL's Week 3 features two Monday Night Football games on Disney's networks, potentially boosting viewership. DraftKings provides betting odds, with several teams favored. Media companies like Disney, Comcast, and Amazon could benefit from increased NFL viewership.

Portfolio Pulse from Chris Katje

September 19, 2024 | 8:34 pm

GEOS

Geospace Technologies has announced a strategic realignment into three new business segments: Smart Water, Energy Solutions, and Intelligent Industrial. This move aims to enhance focus and growth in these areas.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 8:31 pm

ET

KBR

KBR and Technip Energies' joint venture, KTJV, has been selected by Lake Charles LNG Export Company, a subsidiary of Energy Transfer LP, for a major LNG transformation project. The project aims to convert an import facility into an export facility, enhancing global LNG supply.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 8:24 pm

TECX

Tectonic Therapeutic announced positive Phase 1a results for TX45, showing it was well-tolerated with no immunogenicity and a favorable PK/PD relationship. This data will guide Phase 2 trials, with further results expected in 2025.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 8:11 pm

SONY

Sony Group Corp. (NYSE:SONY) is celebrating 30 years of PlayStation with a special 30th Anniversary Collection, featuring limited edition PS5 Pro and Slim models. The PS5 Pro bundle is limited to 12,300 units and includes retro-themed accessories. Preorders start on September 26, 2024.

Portfolio Pulse from Franca Quarneti

September 19, 2024 | 8:10 pm

TNON

Tenon Medical shares rose following the announcement of three notices of allowance for patent applications from the USPTO.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 8:09 pm

TNON

Tenon Medical has received three Notices of Allowance for its patent applications from the USPTO, indicating that the patents will be granted soon. This development could enhance Tenon Medical's intellectual property portfolio.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 8:09 pm